Telemonitoring Systems

Telemonitoring Systems

Global Telemonitoring Systems Market to Reach US$4.5 Billion by 2030

The global market for Telemonitoring Systems estimated at US$2.5 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. COPD Monitoring End-Use, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Blood Pressure Monitoring End-Use segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$657.6 Million While China is Forecast to Grow at 11.4% CAGR

The Telemonitoring Systems market in the U.S. is estimated at US$657.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$986.7 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Telemonitoring Systems Market - Key Trends and Drivers Summarized

What Are Telemonitoring Systems and Why Are They Critical in Healthcare?
Telemonitoring systems enable healthcare providers to remotely monitor patients’ vital signs, symptoms, and overall health conditions using digital communication technologies. These systems are essential for chronic disease management, post-acute care, and elderly care, providing continuous monitoring without the need for frequent hospital visits. By transmitting real-time data such as blood pressure, heart rate, glucose levels, and oxygen saturation, telemonitoring systems allow healthcare professionals to make timely interventions, adjust treatment plans, and improve patient outcomes. This is particularly vital in the context of an aging population and increasing incidences of chronic diseases such as diabetes and cardiovascular conditions, where proactive monitoring is key to reducing hospitalizations and managing healthcare costs.

How Are Telemonitoring Systems Being Used Across Healthcare Settings?
Telemonitoring systems are widely used in hospitals, clinics, and home healthcare settings, providing flexibility for both patients and providers. In hospital settings, telemonitoring is integrated into broader telehealth strategies, allowing clinicians to track the recovery of patients post-surgery or during treatment for chronic conditions. In home healthcare, telemonitoring empowers patients to self-manage their health, while doctors and nurses can access patient data remotely to make informed decisions. This is particularly beneficial in rural areas where access to healthcare facilities is limited. Additionally, telemonitoring systems are employed in specialized care, such as remote monitoring for patients undergoing rehabilitation, as well as for maternity and pediatric care to ensure continuous oversight without frequent hospital visits.

What Are the Key Segments in the Telemonitoring Systems Market?
Key components include devices (such as sensors, wearables, and mobile health apps) and services (such as data collection, analytics, and real-time reporting). Applications span chronic disease management, post-acute care, preventive care, and elderly care. In terms of end-use, hospitals, home care settings, and clinics form the primary market segments. Regionally, North America leads the market due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by increasing adoption of telehealth technologies and government initiatives to improve healthcare access in remote areas. Emerging markets are also contributing to growth as healthcare providers embrace telemonitoring to address infrastructure challenges.

The Growth in the Telemonitoring Systems Market Is Driven by Several Factors
The growth in the telemonitoring systems market is driven by several factors, including the rising prevalence of chronic diseases, the growing elderly population, and advancements in wearable and wireless technologies. The increasing focus on home healthcare solutions, which allow patients to manage their conditions from home, is significantly boosting the demand for telemonitoring systems. Additionally, regulatory support for telehealth and reimbursement policies in regions like North America and Europe are fueling market expansion. The integration of AI and machine learning into telemonitoring systems is further enhancing predictive analytics capabilities, enabling more proactive care. The rapid adoption of 5G technology, which facilitates real-time data transmission with minimal latency, is also expected to accelerate market growth.

Select Competitors (Total 26 Featured) -
  • Abbott Laboratories
  • Aerotel Medical Systems (19) Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • Dream Systems LLC.
  • eVisit, Inc.
  • General Electric Company
  • Honeywell Life Care Solutions
  • Huawei Technologies Co., Ltd.
  • InTouch Health
  • LifeWatch AG
  • McKesson Corporation
  • Medtronic, Inc.
  • Philips Healthcare USA
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Telemonitoring Systems – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Chronic Diseases Drives Adoption of Telemonitoring Systems
Rising Demand for Remote Patient Monitoring Strengthens Business Case for Telemonitoring
Growth of the Elderly Population Spurs Demand for Telemonitoring Solutions
Advancements in Wireless and Wearable Technologies Propel Growth in Telemonitoring
Expanding Use of Telemonitoring in Post-Acute Care Accelerates Market Expansion
Rising Healthcare Costs Drive Adoption of Cost-Effective Remote Monitoring Systems
Integration of AI and Machine Learning in Telemonitoring Systems Enhances Market Growth
Increased Focus on Home Healthcare Solutions Spurs Demand for Telemonitoring
Growing Use of Telemonitoring for Managing Diabetes and Cardiovascular Diseases Propels Market
Shift Toward Value-Based Care Strengthens Demand for Remote Monitoring Solutions
Emergence of 5G Technology Accelerates Adoption of Real-Time Telemonitoring
COVID-19 Pandemic Throws the Spotlight on Remote Monitoring and Telehealth Solutions
Rising Demand for Real-Time Data Analytics and Predictive Insights in Healthcare Sustains Growth
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Telemonitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for COPD Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Blood Pressure Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Glucose Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Cardiovascular Disease Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: Canada 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 26: Japan Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Japan Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Japan 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 29: China Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: China Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: China 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 32: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: Europe Historic Review for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Europe 16-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 35: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Europe 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 38: France Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: France Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: France 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 41: Germany Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Germany Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Germany 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Italy Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Italy 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 47: UK Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: UK Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: UK 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 50: Spain Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Spain Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Spain 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 53: Russia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Russia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Russia 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Rest of Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Rest of Europe 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 60: Asia-Pacific Historic Review for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Asia-Pacific 16-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Asia-Pacific 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 65: Australia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Australia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Australia 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 68: India Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: India Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: India 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 71: South Korea Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: South Korea Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: South Korea 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Rest of Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 77: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 78: Latin America Historic Review for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Latin America 16-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 80: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Latin America 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 83: Argentina Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Argentina Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Argentina 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 86: Brazil Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Brazil Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Brazil 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 89: Mexico Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Mexico Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Mexico 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Latin America 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 95: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 96: Middle East Historic Review for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Middle East 16-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 98: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Middle East 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 101: Iran Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Iran Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Iran 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 104: Israel Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Israel Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Israel 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Saudi Arabia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Saudi Arabia 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 110: UAE Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UAE Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UAE 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Rest of Middle East 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 116: Africa Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Africa Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Africa 16-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings